MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that Canadian-based Mackie Research Capital Corporation has been appointed as lead manager for the equity financing component of the Company's proposed TSX-V listing.
MMJ PhytoTech Limited (ASX:MMJ) wishes to advise that it is fully supportive of recent amendments to Australian Commonwealth legislation, legalising cannabis-based products for medicinal or research purposes as controlled drugs.
MMJ PhytoTech Ltd (ASX:MMJ) advises that it has executed a binding Term Sheet with Canadian-based Harvest One Capital Corp. for the sale to Harvest One of 100% of the issued shares of United Greeneries Holdings Ltd and Satipharm AG respectively.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide its quarterly activities report for the period ended 30 September 2016.
MMJ PhytoTech Ltd (ASX:MMJ) is pleased to provide the company's Annual Report to shareholders.
Traditional Therapy Clinics Ltd (ASX:TTC) is pleased to advise that it has received the third instalment of the Head Office building refund of RMB38.4 million from the building developer.
MMJ PhytoTech Limited (ASX:MMJ) has raised A$4 million through the placement of 19,512,196 fully paid ordinary shares ("Placement") to institutional and sophisticated investors at $0.205 per share.
